DK0699677T3 - Stereoselektiv fremgangsmåde til fremstilling af dihydro-2-benzodiazepinderivater - Google Patents

Stereoselektiv fremgangsmåde til fremstilling af dihydro-2-benzodiazepinderivater

Info

Publication number
DK0699677T3
DK0699677T3 DK95306051T DK95306051T DK0699677T3 DK 0699677 T3 DK0699677 T3 DK 0699677T3 DK 95306051 T DK95306051 T DK 95306051T DK 95306051 T DK95306051 T DK 95306051T DK 0699677 T3 DK0699677 T3 DK 0699677T3
Authority
DK
Denmark
Prior art keywords
benzodiazepine derivatives
stereoselective method
preparing dihydro
dihydro
preparing
Prior art date
Application number
DK95306051T
Other languages
English (en)
Inventor
Marvin Martin Hansen
Jeffrey Thomas Vicenzi
David Lee Varie
Benjamin Anderson
Milton Joseph Zmijewski
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/413,036 external-priority patent/US5665878A/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of DK0699677T3 publication Critical patent/DK0699677T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • C07D491/056Ortho-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58Radicals substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK95306051T 1994-08-31 1995-08-30 Stereoselektiv fremgangsmåde til fremstilling af dihydro-2-benzodiazepinderivater DK0699677T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29864594A 1994-08-31 1994-08-31
US08/413,036 US5665878A (en) 1994-08-31 1995-03-28 Stereoselective process for producing dihydro-2,3-benzodiazepine derivatives

Publications (1)

Publication Number Publication Date
DK0699677T3 true DK0699677T3 (da) 2003-04-22

Family

ID=26970799

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95306051T DK0699677T3 (da) 1994-08-31 1995-08-30 Stereoselektiv fremgangsmåde til fremstilling af dihydro-2-benzodiazepinderivater

Country Status (22)

Country Link
US (3) US5919954A (da)
EP (1) EP0699677B1 (da)
JP (1) JP3481019B2 (da)
KR (1) KR100399518B1 (da)
CN (1) CN1086705C (da)
AT (1) ATE231867T1 (da)
AU (1) AU702658B2 (da)
BR (1) BR9503845A (da)
CA (1) CA2157234C (da)
CZ (1) CZ295675B6 (da)
DE (1) DE69529499T2 (da)
DK (1) DK0699677T3 (da)
ES (1) ES2189819T3 (da)
FI (1) FI113269B (da)
HK (1) HK1013818A1 (da)
HU (1) HU223776B1 (da)
IL (1) IL115100A (da)
IN (1) IN190402B (da)
NO (1) NO312838B1 (da)
PL (3) PL188796B1 (da)
RU (1) RU2151149C1 (da)
TR (1) TR199501071A2 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA67749C2 (uk) * 1997-08-12 2004-07-15 Егіш Дьйодьсердьяр Рт. Похідна 8-заміщеного-9н-1,3-діоксол/4,5-h//2,3/бензодіазепіну з властивостями амра/каїнатного антагоніста, спосіб одержання похідних, фармацевтична композиція (варіанти), спосіб її одержання та спосіб лікування
NZ503301A (en) * 1997-08-12 2002-09-27 Egyt Gyogyszervegyeszeti Gyar 1,3-dioxolo[4,5-h][2,3]benzodiazepine derivatives useful as AMPA/Kainate receptor inhibitors
WO1999023242A1 (en) * 1997-11-04 1999-05-14 Eli Lilly And Company Ketoreductase gene and protein from yeast
US20030219456A1 (en) * 2002-05-21 2003-11-27 Taing Ok Method of utilization of zygosaccharomyces rouxii
US6858605B2 (en) 2003-02-04 2005-02-22 Ivax Drug Research Institute, Ltd. Substituted 2,3-benzodiazepine derivatives
ATE425817T1 (de) * 2005-12-05 2009-04-15 Deutsche Post Ag Verfahren zum sortieren von postsendungen und vorrichtung mit einer datenstruktur fur einen sortierplan
CA2633804A1 (en) * 2005-12-30 2007-07-12 Egis Gyogyszergyar Nyilvanosan Mukodo Reszvenytarsasag Optical isomers of dihydro-2,3-benzodiazepines and their stereoselective synthesis
KR100841592B1 (ko) 2007-04-16 2008-06-26 한양대학교 산학협력단 벤조디옥솔 유도체와 이의 제조방법

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3794642A (en) * 1973-01-15 1974-02-26 Lilly Co Eli Oxidation of substituted methanes to the corresponding substituted methanols
DE2816475A1 (de) * 1978-04-15 1979-10-25 Bayer Ag Isochroman-derivate, verfahren zu ihrer herstellung und ihre verwendung als synergisten in insektiziden und akariziden mitteln
US4358041A (en) 1980-06-12 1982-11-09 Olin Corporation Powder-actuated tool with power adjustment and angle-fire control
HU191702B (en) * 1984-06-27 1987-03-30 Gyogyszerkutato Intezet New process for preparing 1-aryl-5 h-2,3-benzodiazepines
HU191698B (en) * 1984-07-27 1987-03-30 Gyogyszerkutato Intezet Process for producing new 1-aryl-5h-2beta-benzodiazepines
HU198494B (en) 1986-08-15 1989-10-30 Gyogyszerkutato Intezet Process for producing new 3,4-dihydro-5h-2,3-benzodiazepine derivative and acid addition salts thereof, as well as pharmaceutical compositions comprising same
EP0357787B1 (en) * 1988-02-12 1996-05-08 Daicel Chemical Industries, Ltd. Process for preparing optically active 2-hydroxy acid derivatives
JP2679145B2 (ja) * 1988-09-02 1997-11-19 ダイセル化学工業株式会社 オキシケトンの製造法
HU219778B (hu) * 1990-12-21 2001-07-30 Gyógyszerkutató Intézet Közös Vállalat Eljárás N-acil-2,3-benzodiazepin-származékok, savaddíciós sóik és az ezeket tartalmazó gyógyászati készítmények előállítására, valamint a vegyületek egy csoportja, és az ezeket tartalmazó gyógyászati készítmények
HU206719B (en) 1990-12-21 1992-12-28 Gyogyszerkutato Intezet Process for producing 1-/4-acylamino-phenyl/-7,8-methylenedioxy-5h-2,3-benzodiazepine derivatives, acid addicional salts and pharmaceutical compositions containing them
JP3061422B2 (ja) * 1990-12-27 2000-07-10 ダイセル化学工業株式会社 光学活性(s)−2−クロロ−1−フェニルプロパノールの製造法
JPH04271789A (ja) * 1991-01-10 1992-09-28 Takeda Chem Ind Ltd D−パントラクトンの製造方法
HU219777B (hu) * 1993-07-02 2001-07-30 Gyógyszerkutató Intézet Kft. Optikailag aktív 1-(4-nitro-fenil)-4-metil-7,8-metiléndioxi-3,4-dihidro-5H-2,3-benzodiazepin és eljárás előállítására

Also Published As

Publication number Publication date
HUT72644A (en) 1996-05-28
PL310226A1 (en) 1996-03-04
US6160133A (en) 2000-12-12
NO953396D0 (no) 1995-08-30
AU3035595A (en) 1996-03-14
JP3481019B2 (ja) 2003-12-22
CA2157234C (en) 2005-05-03
HU223776B1 (hu) 2005-01-28
BR9503845A (pt) 1996-04-16
US5986114A (en) 1999-11-16
PL190640B1 (pl) 2005-12-30
NO312838B1 (no) 2002-07-08
CN1123282A (zh) 1996-05-29
AU702658B2 (en) 1999-02-25
FI113269B (fi) 2004-03-31
CZ221995A3 (en) 1996-03-13
KR100399518B1 (ko) 2004-04-30
CN1086705C (zh) 2002-06-26
HU9502545D0 (en) 1995-10-30
DE69529499D1 (de) 2003-03-06
ES2189819T3 (es) 2003-07-16
ATE231867T1 (de) 2003-02-15
IL115100A (en) 2000-07-26
HK1013818A1 (en) 1999-09-10
EP0699677A1 (en) 1996-03-06
PL190318B1 (pl) 2005-11-30
CA2157234A1 (en) 1996-03-01
PL188796B1 (pl) 2005-04-29
US5919954A (en) 1999-07-06
NO953396L (no) 1996-03-01
JPH0881468A (ja) 1996-03-26
IL115100A0 (en) 1995-12-08
FI954064A (fi) 1996-03-01
EP0699677B1 (en) 2003-01-29
DE69529499T2 (de) 2003-12-04
CZ295675B6 (cs) 2005-09-14
FI954064A0 (fi) 1995-08-30
TR199501071A2 (tr) 1996-06-21
KR960007595A (ko) 1996-03-22
IN190402B (da) 2003-07-26
RU2151149C1 (ru) 2000-06-20

Similar Documents

Publication Publication Date Title
PT778277E (pt) Derivados heterociclicos substituidos como antagonistas do crf
NO932870D0 (no) Ny fremgangsmaate for fremstilling av 9-amino-6-demetyl-6-deoksyetracykliner
HU911771D0 (en) Process for producing substituted and heterocyclic phthalides
HU9601857D0 (en) New benzyl-piperidine- or -tetrahydro-pyridine derivatives and processes for producing them
DK0699677T3 (da) Stereoselektiv fremgangsmåde til fremstilling af dihydro-2-benzodiazepinderivater
DK0503453T3 (da) Fremgangsmåde til fremstilling af cephalosporiner og mellemprodukter i denne fremgangsmåde
CA2273303A1 (en) Thienylsulfonylamino(thio)carbonyl compounds
MY117754A (en) Stereoselective process for producing dihydro-2, 3-benzodiazepine derivatives
ATE353937T1 (de) Verfahren zur synthese einer oxonolverbindung
PT85570A (fr) Procede de preparation de derives de 2,3-dihydro furanne utilisables comme intermediaires pour la preparation de tetrahydrofuranne
AU3210593A (en) Improvements in or relating to organic compounds
DK0949250T3 (da) Fremgangsmåde til fremstilling af alpha1L-adrenoceptorantagonister
DK0521766T3 (da) Hidtil ukendt fremgangsmåde til syntese af enantiomerer af 3-aminochromanderivater
ATE364600T1 (de) Verfahren zur herstellung von indol-derivaten und intermediaten dafür
DE69816773D1 (de) Verfahren zur herstellung von 1,4-benzodioxan-derivaten
ATE71367T1 (de) Verfahren zur herstellung von indolinen.
BR9610392A (pt) Processo para a preparação de derivados de rodanina substituídos com benzila
DE3864463D1 (de) Gamma-l-glutanyl-4-nitoanilid-derivate und verfahren zur bestimmung von gamma-gtp-aktivitaet unter verwendung dieser derivate.
DK358486D0 (da) Fremgangsmaade til fremstilling af 2-acyl-3,4-dialkoxyaniliner